when is tirzepatide approved FDA approves new version of diabetes drug Mounjaro to be sold for weight loss FDA approval for Zepbound (tirzepatide)
Description
Real-World Evidence: A retrospective cohort study using electronic health record data found that tirzepatide was associated with a mean weight loss of 6.6 kg compared to 3.1 kg for semaglutide over a 6-month follow-up period

Tirzepatide is also good for treating diabetes under the name Mounjaro
Physician-Guided Weight Loss Program Medically Supervised Tirzepatide Prescribed Online Experience medically supervised weight management with professional Tirzepatide Delivery from InjectCo

The finer graduations reduce measurement error

The weight loss itself improves fertility in individuals with obesity related infertility, potentially leading to unplanned pregnancy

Even if the telehealth service is based in another state, the doctor needs to be legally allowed to treat patients where you live
